HTSF is open for all Business!


We have, however, modified the way we work over the last months and this will continue in light of social distancing rules:

  1. We will be electronically accepting samples as in the past.
  2. We have a secure contactless dropped off. Sample Drop Off is required during a prescheduled 30m window rather than when you are ready.
  3. This may delay drop off for 24hrs if we are booked on a given day. After a submission is accepted, we will confirm day/ time with you.
  4. We ask that you stick to this window to prevent overlap with other studies and to maintain SOM social distancing requirements.
  5. You will need to enter the double glass doors closest to HTSF rm. 1153. This is the stipulated “IN” door for the building.
  6. As previously, please confirm your quote and print out a confirmed manifest to bring with your samples.

The HTSF directors and managers will continue to be here to answer questions/concerns, have conference calls and zoom meetings.
Samples will be processed on first come, first serve basis. We expect a queue to form for some services. Please contact customer service with concerns about timelines. HTSF cannot guarantee turn around at this point. We are currently working at approx. 70% of overall production from prior to COVID. The staff are working as quickly as they can and are 100% busy when they are present. HTSF staff numbers are limited as all labs are open in GSB. We regret the delays and inconvenience this exceptional circumstance has caused.
We know that everyone is anxious to get back to the bench and start generating more data. Please be assured that we are working quickly as we can under the current restrictions. As restrictions are modified, our production levels will follow suit.

Thank you for working with us in this ever changing situation
The HTSF Staff

Welcome to the High Throughput Genomic Sequencing Facility

 

History and Mission

The HTSF was established in 2008 with funds from the University Cancer Research Fund (UCRF) and the Lineberger Comprehensive Cancer Center (LCCC) and is managed by the UNC School of Medicine.

Our primary goal is to apply the tools of high throughput sequencing technology and experience to enrich medicine and basic biological research at The University of North Carolina. High-throughput sequencing is an extremely fast developing technology that is used to extract genetic and genomic data from a broad spectrum of biological materials. This information is not only be used to help identify the causes of complex diseases such as cancer, diabetes and cardiovascular disease and demonstrate the underlying bases for multiple types of infectious diseases.  It can be also used to analyze the complexities of diverse biological systems. Our goal is to support UNC researchers, students, and their collaborators in their work with our state-of-the-art technology to make medical and scientific breakthroughs happen.

We support all commercially available high throughput sequencing platforms and regularly work with researchers to develop and implement novel cutting edge applications with these platforms. We frequently work directly with the developers of new systems as an early access customer to give them useful feedback and to give our researchers the earliest possible access to novel new technologies.